Odyssey Therapeutics (ODTX) Income Statement

Odyssey Therapeutics reported revenue of $2.98M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 33.5% from $4.47M a year earlier. Odyssey Therapeutics posted a net loss of $148.65M, compared with a net loss of $130.40M a year earlier. Gross margin was 100.0% and operating margin -5415.2%.

Odyssey Therapeutics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Odyssey Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	2.98	4.47	1.04	-
Cost of Revenue	121.18	112.58	112.28	101.52
Gross Profit	2.98	4.47	1.04	-
Operating Expenses
Research & Development	126.62	112.58	112.28	101.76
Selling, General & Administrative	37.52	27.12	22.20	21.02
Operating Expenses	164.13	141.49	134.48	127.90
Operating Income	-161.16	-137.02	-133.44	-127.90
Other Income/Expense
Interest Income	6.35	8.49	8.79	3.92
Interest Expense	0.02	0.02	0.34	0.29
Other Income/Expense	5.25	8.17	-0.51	3.59
Income
Income Before Tax	-149.57	-128.85	-125.49	-124.32
Income Tax Expense	-0.93	0.47	0.45	0.35
Net Income	-148.65	-130.40	-125.94	-124.67
Net Income - Continuous Operations	-148.65	-129.32	-125.94	-124.67
Net Income - Discontinued Operations	-	-	-	-
EBITDA	-144.65	-130.03	-120.25	-119.77
EBIT	-149.56	-135.22	-125.16	-122.54
Depreciation & Amortization	4.91	5.19	4.91	2.76
Earnings Per Share
Basic EPS	-5.00	-162.00	-1.00	-278.00
Diluted EPS	-5.00	-148.00	-1.00	-278.00
Basic Shares Outstanding	27.56	0.81	99.23	0.45
Diluted Shares Outstanding	27.56	0.81	99.23	0.45

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Odyssey Therapeutics Financial Statements

What was Odyssey Therapeutics's revenue in fiscal 2025?

Odyssey Therapeutics reported revenue of $2.98M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 33.5% from $4.47M a year earlier.

Is Odyssey Therapeutics profitable?

No. Odyssey Therapeutics reported a net loss of $148.65M in fiscal 2025. In fiscal 2024 it lost $130.40M.

What is Odyssey Therapeutics's operating margin?

Odyssey Therapeutics's operating income was −$161.16M on revenue of $2.98M in fiscal 2025, an operating margin of -5415.2%, compared with -3064.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition